The Drama of Wallerian Degeneration: The Cast, Crew, and Script.


Journal

Annual review of genetics
ISSN: 1545-2948
Titre abrégé: Annu Rev Genet
Pays: United States
ID NLM: 0117605

Informations de publication

Date de publication:
23 11 2021
Historique:
pubmed: 6 8 2021
medline: 22 3 2022
entrez: 5 8 2021
Statut: ppublish

Résumé

Significant advances have been made in recent years in identifying the genetic components of Wallerian degeneration, the process that brings the progressive destruction and removal of injured axons. It has now been accepted that Wallerian degeneration is an active and dynamic cellular process that is well regulated at molecular and cellular levels. In this review, we describe our current understanding of Wallerian degeneration, focusing on the molecular players and mechanisms that mediate the injury response, activate the degenerative program, transduce the death signal, execute the destruction order, and finally, clear away the debris. By highlighting the starring roles and sketching out the molecular script of Wallerian degeneration, we hope to provide a useful framework to understand Wallerian and Wallerian-like degeneration and to lay a foundation for developing new therapeutic strategies to treat axon degeneration in neural injury as well as in neurodegenerative disease.

Identifiants

pubmed: 34351802
doi: 10.1146/annurev-genet-071819-103917
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-113

Auteurs

Kai Zhang (K)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China; email: zhangkai@sioc.ac.cn, jiangms@sioc.ac.cn, fangys@sioc.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.

Mingsheng Jiang (M)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China; email: zhangkai@sioc.ac.cn, jiangms@sioc.ac.cn, fangys@sioc.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.

Yanshan Fang (Y)

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201203, China; email: zhangkai@sioc.ac.cn, jiangms@sioc.ac.cn, fangys@sioc.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH